Title:
CHOLERA VACCINE AND MANUFACTURE
Document Type and Number:
Japanese Patent JPS5877821
Kind Code:
A
Abstract:
Vibrio cholerae, Ogawa serotype, El Tor biotype, are subjected to the mutagenic N-methyl-N'-nitro-n-nitrosoguanidine (NTG). First generation mutants are screened for toxin production, and in particular the absence of «A» or enzymatically active subunit production and production of B (binding) subunit. Putative A- B+ mutants are again exposed to NTG and screened for the A- B+ characteristics. The formulae of the native toxin molecule is usually A- B+ 5-6, the formulae for the molecule produced by the selected second generation mutant is A- B+ 5-6. This mutant strain is used for production of a live attenuated vaccine which can be administered orally. The mutant has been found to induce immunity, in an experimental model system, to subsequent challenge with virulent cholera vibrios. Because of the immunologic relatedness of other enterotoxins (such as the heat-labile enterotoxin of Escherichia coli), the mutant may also induce immunity to other diarrheal diseases than cholera. In fact, antiserum to the isolated toxin-related protein produced by the mutant has been shown to neutralize E. coli enterotoxin. The mutant may also be used for the production of ccholera- genoid», the non-toxic, highly immunogenic B portion of the cholera enterotoxin (choleragen) without the complication of toxicity of the product.
Inventors:
HONDA TAKESHI
RICHIYAADO EI FUINKERUSUTAIN
RICHIYAADO EI FUINKERUSUTAIN
Application Number:
JP18151982A
Publication Date:
May 11, 1983
Filing Date:
October 15, 1982
Export Citation:
Assignee:
ZA UNIV OBU TEKISASU SYSTEM
International Classes:
A61K39/106; C12N15/01; C12N1/20; (IPC1-7): A61K39/106
Attorney, Agent or Firm:
Kazuo Sato